Cannabis producer HEXO Corp. (NASDAQ: HEXO) has reported a wider net loss for the second quarter of 2022. However, the Canada-based company's
Categories
Cannabis
Infographic: Everything you need to know about Aurora Cannabis’ (ACB) Q2 earnings
Aurora Cannabis, Inc. (NYSE: ACB) on Thursday reported a narrower net loss for the second quarter of 2022. The company's revenues dropped
Altria Group, Inc. (MO) Q4 2021 Earnings Call Transcript
Altria Group, Inc. (NYSE: MO) Q4 2021 earnings call dated Jan. 27, 2022 Corporate Participants: Mac Livingston -- Vice President of Investor Relations Billy
Infographic: How Tilray (TLRY) performed in Q2 2022
Tilray (NASDAQ: TLRY) reported second-quarter 2022 financial results before the regular market hours on Monday. Total net revenue increased 20% year-over-year to
Hexo Corp. (HEXO) Earnings: 1Q22 Key Numbers
HEXO Corp. (NASDAQ: HEXO) reported total revenue of CAD50.2 million for the first quarter of 2022, which was up 70% year-over-year. Total
Hexo Corp. (HEXO) Earnings: 4Q21 Key Numbers
HEXO Corp. (NASDAQ: HEXO) reported total revenue of CAD38.7 million for the fourth quarter of 2021, which was up 43% year-over-year. Total
ACB Earnings: Aurora Cannabis Q1 2022 revenue down 11%
Aurora Cannabis, Inc. (NYSE: ACB) on Tuesday reported a loss for the first quarter of 2022 when its revenues declined 11% from
Canopy Growth (CGC) Earnings: 2Q22 Key Numbers
Canopy Growth Corporation (NASDAQ: CGC) reported second quarter 2022 earnings results today. Net revenue decreased 3% year-over-year to CAD131 million. Excluding the
Resonate Blends CIO David Thielen: Spent the last 18 months cleaning up our balance sheet
How is Resonate Blends different from other cannabis-based products? We became a public company in late 2019 through a reverse merger with
Infographic: Highlights of Aurora Cannabis (ACB) Q4 2021 earnings report
Aurora Cannabis, Inc. (NYSE: ACB) on Monday reported a net loss for the fourth quarter of 2021, continuing the recent trend. However,
Canopy Growth Corp (CGC) Q1 2022 Earnings Call Transcript
Canopy Growth Corp (NASDAQ: CGC) Q1 2022 earnings call dated Aug. 06, 2021. Company Participants: Judy Hong -- Vice President of Investor
Canopy Growth Corporation (CGC) Earnings: 1Q22 Key Numbers
Canopy Growth Corporation (NASDAQ: CGC) reported first quarter 2022 earnings results today. Total revenue increased 23% year-over-year to CAD136 million, driven by
Delta 9 Cannabis CEO John Arbuthnot: We want to grow while being profitable
Credit: Delta 9 Tell us a bit about the business, the market opportunity, and the competition Founded in 2013, we became the
Tilray, Inc. (TLRY) Q4 2021 Earnings Call Transcript
Tilray, Inc. (NASDAQ: TLRY) Q4 2021 earnings call dated Jul. 28, 2021 Corporate Participants: Raphael Gross -- Investor Relations Berrin Noorata -- Chief Corporate Affairs Officer
HEXO Corp. (HEXO) Earnings: 3Q21 Key Numbers
HEXO Corp. (NYSE: HEXO) reported its third-quarter 2021 earnings results today. Net revenue rose 2% year-over-year to CAD22.6 million. Net loss narrowed
Canopy Growth Corporation (CGC) Q4 2021 Earnings Call Transcript
Canopy Growth Corporation (NASDA: CGC) Q4 2021 earnings call dated June 01, 2021 Company Participants: Judy Hong -- Vice President, Investor Relations and Competitive Intelligence
Canopy Growth Corporation (CGC) Q4 Earnings: Key financials and quarterly highlights
Canopy Growth Corporation (NYSE: CGC) reported fourth-quarter 2021 earnings results today. Net revenues increased 38% year-over-year to CAD $148 million. Net loss attributable
Delta 9 Cannabis Inc. (DLTN) Q1 2021 Earnings Call Transcript
Delta 9 Cannabis Inc. (DLTN) Q1 2021 earnings conference call data May. 17, 2021 Corporate Participants: Alexa Goertzen -- Manager of Corporate Affairs &
Aurora Cannabis (ACB) Earnings: 3Q21 Key Numbers
Aurora Cannabis Inc. (NYSE: ACB) reported third quarter 2021 earnings results today. Total revenues fell 25% year-over-year to CAD55.1 million. Adjusted EBITDA
Cronos Group (CRON) Earnings: 1Q21 Key Numbers
Cronos Group Inc. (NASDAQ: CRON) reported first-quarter 2021 earnings results today. The net revenue for the first quarter was $12.6 million with
Favorable Cannabis Act review will amplify edibles demand: OrganiGram CEO Greg Engel
OrganiGram (NASDAQ: OGI) had trailed its Canadian rivals in expanding its geographic presence through strategic partnerships, till it finally established an alliance